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Abstract 1 
Quercetin is a flavonoid with antioxidant/anti-inflammatory properties, poorly absorbed when 2 
administered orally. To increase its bioavailability and optimize its release in the intestine, a hybrid 3 
system made of liposomes coated with cross-linked chitosan, named TPP-chitosomes, was 4 
developed and characterized by light scattering, transmission electron microscopy, differential 5 
scanning calorimetry, X-ray powder diffraction and Turbiscan® technology. The TPP-chitosomes 6 
were nanosized (~180 nm), fairly spherical in shape and unilamellar. The actual coating of the 7 
surface of liposomes with the cross-linked chitosan was demonstrated by Small-Angle X-ray 8 
Scattering. 9 
The release of quercetin in simulated gastric and intestinal pH was investigated, the results showing 10 
that the system provided resistance to acidic conditions, and promoted the release in alkaline pH, 11 
mimicking the intestinal environment. 12 
The proposed hybrid system represents a promising combination of nanovesicles and chitosan for 13 
the delivery of quercetin to the intestine in the therapy of oxidative stress/inflammation related 14 
disorders. 15 
 16 
 17 
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1. Introduction 
Quercetin (3,3’,4’,5,7-pentahydroxyflavone) is a flavonoid present in a large number of edible 
vegetables and fruits [1,2]. This molecule has many health-promoting effects, including 
improvement of cardiovascular health, reducing risk for cancer, and coping with inflammatory 
disorders, mainly related to its strong antioxidant action, by which it upregulates the endogenous 
free radical defenses [3,4]. However, the efficacy of quercetin is limited due to its hydrophobicity, 
instability in physiological media, poor gastrointestinal absorption, and extensive xenobiotic 
metabolism at intestines and liver (i.e., glucuronidation or sulfation), which collectively contribute 
to its low oral bioavailability [4-6,7]. Various nanotechnological approaches have been used to 
enhance its solubility, dissolution rate, and hence, bioavailability, including solid dispersions, 
nanosuspensions, microemulsions, solid lipid nanoparticles and prodrugs [8-12]. Therefore, a 
critical need exists to develop alternative formulative strategies to overcome the shortcomings of 
quercetin and enhance its bioavailability. 
The objective of this study was to develop, optimize and thoroughly characterize a formulation that 
enhances quercetin local bioavailability, bypasses the stomach and allows its release in the intestine 
for the treatment of disorders in which oxidative stress and inflammation are involved [2,13,14]. 
Among the different approaches to achieve intestinal drug delivery, the use of natural polymers 
holds promise. In recent years, polymer-coated liposomes have been proposed for the targeted 
delivery of drugs to the inflamed intestinal mucosa, upon oral administration [14]. Conventional 
liposomes can be hardly used, due to their low resistance to gastric pH and enzymatic degradation, 
but they can be easily protected by a polymeric coating. Chitosan is one of the most widely used 
polymers for coating liposomes. It is a linear cationic polysaccharide comprised of (1→4)-linked 
units of glucosamine and N-acetyl-glucosamine, mainly produced by partial deacetylation of chitin. 
Due to its unique and attractive properties, including biocompatibility, biodegradability, 
biorenewability and bioadhesion, chitosan is widely explored for biopharmaceutical applications, 
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especially for intestinal drug delivery [15,16]. However, it has a limited capacity for controlling 
drug release from oral dosage forms due to its fast dissolution in the stomach. To overcome this 
disadvantage, three dimensional networks have been developed by non-covalent complexation 
relying on electrostatic, hydrophobic and/or hydrogen bonding forces. The cationic amino groups of 
the repeating glucosamine units of chitosan can interact electrostatically with the anionic groups of 
other polyions to form polyelectrolyte complexes. These cross-linking interactions are physical in 
nature and reversible, but can provide the required properties for optimal drug delivery if the 
polymer is properly complexed. In a previous work, chitosan was complexed with Nutriose FM06®, 
a branched dextrin obtained from starch, and used to coat polyethylene glycol-containing vesicles, 
with the aim of producing an enzyme-sensitive, prebiotic, delayed release system for the delivery of 
quercetin to inflamed colon [14]. 
In the present paper, chitosan was complexed with sodium tripolyphosphate and used to coat 
liposomes, thus obtaining a hybrid system conceived for increasing the bioavailability of 
incorporated quercetin and optimizing its release rate to reach the intestine. To achieve these goals, 
it was imperative to assess the effectiveness and feasibility of the system by a thorough 
characterization using different analytical tools, such as Light Scattering, Transmission Electron 
Microscopy (TEM), Differential Scanning Calorimetry (DSC), X-Ray Powder Diffraction (XRPD), 
and Small-Angle X-ray Scattering (SAXS). Further, the ability of the system to release quercetin in 
simulated gastric and intestinal pH was investigated. 
 
2. Materials and methods 
2.1. Materials 
Phospholipon90H and Phospholipon50 (P90H and P50; phosphatidylcholine-based phospholipids) 
were purchased from Lipoid GmbH (Ludwigshafen, Germany). Cholesterol (CHOL), chitosan of 
low molecular weight (50-190 kDa; degree of deacetylation ≥75%), sodium tripolyphosphate 
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(TPP), phosphate buffered saline (PBS, pH 7.4) and quercetin (QUE) were purchased from Sigma-
Aldrich (Milan, Italy). 
 
2.2. Preparation of TPP-chitosan/liposome hybrid system 
P90H (60 mg/ml), P50 (30 mg/ml), CHOL (2 mg/ml) and quercetin (5 mg/ml) were weighed in a 
glass vial, PBS was added and the dispersion was sonicated (5 seconds on and 2 seconds off, 25 
cycles) to obtain liposomes. After that, an equal volume of chitosan dispersion (0.5% w/v) in acetic 
acid/water (0.5 % v/v) was added to the vesicle dispersion to produce chitosomes, which were 
further treated with an equal volume of a TPP aqueous solution (0.2% w/v) to cross-link the 
chitosan, thus obtaining TPP-chitosomes. 
 
2.3. Hybrid system characterization 
The shape and morphology of liposomes, chitosomes and TPP-chitosomes were examined by TEM. 
Samples were stained with 1% phosphotungstic acid and examined with a JEM-1010 microscope 
(Jeol Europe, Paris, France) equipped with a digital camera MegaView III and the software 
“AnalySIS”, at an accelerating voltage of 80 kV. 
The average diameter, polydispersity index (P.I., a measure of the width of size distribution) and 
zeta potential of the systems were determined by Dynamic and Electrophoretic Light Scattering 
(DLS) using a Zetasizer nano-ZS (Malvern Instruments, UK). Samples (n = 6) were diluted with 
PBS (1:100) and analyzed at 25 °C. 
The systems were purified from non-incorporated quercetin by dialysis. Each sample (1 ml) was 
loaded into Spectra/Por® tubing (12–14 kDa MW cut-off; Spectrum Laboratories Inc., DG Breda, 
The Netherlands) and dialyzed against PBS (2 l) for 2 hours, at room temperature. Both non-
dialyzed and dialyzed samples were diluted with methanol (1:100) and assayed by HPLC to 
quantify the content of quercetin in the vesicular systems. A Perkin Elmer® Series 200 HPLC 
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equipped with a fluorescence detector was used; the column was a Kromasil® C18, 5.0 µm (150 
cm×4.6 mm); the mobile phase consisted of acetonitrile : water : acetic acid (80:19.8:0.2 v/v), 
eluted at a flow rate of 1 ml/min. Quercetin was excited at 370 nm and detected at 530 nm. The 
drug entrapment efficiency (EE%; Eq. 1) of the three systems was calculated as follows: 
100% xQUEinitial
QUEactualEE 





=  (Eq. 1) 
where actual QUE is the amount of drug in vesicles after dialysis, and initial QUE is the amount of 
drug before dialysis, as calculated by HPLC. 
X-ray powder diffractograms of the raw materials (i.e., P90H, P50, cholesterol, TPP, quercetin, 
chitosan), physical mixture and lyophilized drug-loaded TPP-chitosomes were recorded by a Bruker 
AXS D8 Advance, with CuKα radiation, equipped with a LynxEye energy-dispersive 1D detector 
(Karlsruhe, Germany) in the 2θ range from 8 to 80°, with steps of 0.02°. 
DSC thermograms of the raw materials, physical mixture and lyophilized quercetin-loaded hybrid 
system were recorded using a DSC Mettler Toledo model 821 (Greifensee, Switzerland). Samples 
(2–5 mg) were scanned in sealed aluminum pans under nitrogen atmosphere. DSC thermograms 
were scanned at a constant rate of 10 °C/min, in a temperature range of 25-400 °C. 
 
2.4. Small Angle X-ray Scattering 
The nanostructure of the hybrid vesicle/polymer systems was studied by SAXS. SAXS patterns 
were recorded using a S3-MICRO (Hecus X-ray systems, Graz, Austria) coupled to a GENIX-Fox 
3D X-ray source (Xenocs, Grenoble, France) working at 50 Kv and 1 mA. This source produces a 
focused X-ray beam with λ =1.542 Å at Cu Kα-line with more than 97% purity and less than 0.3% 
Kβ. The two detectors are position sensitive detectors PSD 50 (Hecus, Graz, Austria). The working 
q range were 0.01 ≤ q ≤ 0.6 Å−1, where q = (4 π sinθ)/λ is the modulus of the scattering wave vector, 
θ the scattering angle and λ the wavelength. The samples were loaded in flow through glass 
7 
 
capillaries and the diffraction patterns were recorded at 25 °C. For each experiment, the scattering 
pattern was recorded as a sum of subscans to verify there was no sample evolution. The scattering 
curves were background subtracted using the same capillary filled with water. To obtain useful 
information from the scattering curves, a home-made minimization routine based on the Leverberg-
Marquad scheme was used. The calculated scattering curves were smeared according to our 
experimental set up, which corresponded to a detector focused beam convoluted with the linear 
detector width. We used a model based on the one developed by Pabst et al. [17] to calculate the 
bilayer electronic profile and its combination with the Caillé structure factor. Contrary to the model 
of Pabst, we also included a constant term through the hydrophobic part of the bilayer, to give 
account of the methylene contribution [18]. Further, in order to simulate asymmetric profiles, the 
description of Varga et al. [19] for the bilayer electronic density was used. In this case, we restricted 
the possible free parameters by allowing only the intensity to be different in both bilayers. 
 
2.5. Accelerated stability studies 
The stability of quercetin hybrid systems was evaluated by standard long-term stability tests, i.e. 
analyzing vesicle mean size, P.I. and zeta potential over one month at 4 °C. Accelerated stability 
tests were also carried out by using the Turbiscan® AG Station (Formulaction, l’Union, France), 
which was previously used to evaluate the stability of colloidal dispersions [20]. The apparatus 
consists in the Turbiscan Lab Expert, which measures the multiple dispersion of the light by 
suspensions, coupled with an Aging Station constituted by a robot with three thermoregulated 
blocks for the storage of the samples. 10 ml of each sample was placed in a glass cell in the 
Turbiscan block and kept at 25 and 40 °C for 15 days. The detection head is composed of a pulsed 
near-infrared light source (λ = 850 nm), a transmission (T) and a backscattering (BS) detector. The 
former receives the light that crosses the sample (at 180° from the incident beam), while the latter 
receives the light scattered backwards by the sample (at 45° from the incident beam). The 
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measurement principle of the Turbiscan® is based on multiple light scattering: the photons are 
scattered many times by the particles before being detected by the backscattering detector. The 
detection head scans the height of the sample cell, acquiring transmitted and backscattered light 
each 40 µm. The intensity of the light backscattered by the sample depends on three parameters: the 
diameter of the particles, their volume fraction and the relative refractive index between the 
dispersed and continuous phases. Therefore, any change due to a variation of the particle size 
(flocculation, coalescence) or a local variation of the volume fraction (migration phenomena: 
creaming, sedimentation) is detected by the optical device. The Turbiscan® makes scans at various 
pre-programmed times and overlays the profiles on one graph, in order to show possible 
destabilization phenomena. In our experiments, the stability of the samples was evaluated on the 
basis of the variation of transmission (∆T), which was elaborated as ∆T profiles by the Turbiscan 
EasySoft Converter showing ∆T in ordinate and the height of the cell in abscissa. 
For a comparative evaluation between the different samples we exploited the Turbiscan Stability 
Index (TSI) computation, that provides a key number related to the general behaviour of the 
formulation. Samples were significantly different for ∆TSI values greater than 0.4. 
 
2.6. In vitro drug release studies 
The in vitro release profile of quercetin from the vesicle dispersions was assessed in two different 
buffered solutions mimicking the gastric and intestinal pH (1.2 and 7.0, respectively), using a USP 
basket dissolution apparatus. The dispersions were loaded in a dialysis tube (see Section 2.3) and 
immersed in the dissolution medium, thermostated at 37.0 ± 0.5 °C. Drug release was assessed: for 
120 min (2 h) at pH 1.2 and for 480 min (8 h) at pH 7.0. At scheduled time intervals, an aliquot of 
the medium was withdrawn and refreshed to ensure sink conditions, and the drug content was 
assayed by HPLC (see Section 2.3). All experiments were performed in triplicate. 
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2.7. Statistical analysis of data 
Results are expressed as the mean ± standard deviation (SD). Multiple comparison of means 
(Tukey’s test) was used to substantiate statistical differences between groups, while Student’s t-test 
was used to compare two samples. Significance was tested at the 0.05 level of probability (p). Data 
analysis was carried out with the software package R, version 3.1.2. 
 
3. Results and discussion 
3.1. Hybrid system’s fabrication and key features 
A hybrid system made of quercetin-loaded liposomes coated with TPP cross-linked chitosan was 
developed aiming at realizing an efficient intestinal delivery system by exploiting the attractive 
biopharmaceutical properties of the flavonoid, the phospholipid vesicles, and the polymer, as well. 
The polycationic chitosan was dissolved in acetic acid solution to protonate the free amino groups 
and allow the supramolecular self-organizing interaction with negatively charged liposomes on the 
one hand, and with negatively charged polyanion TPP, acting as a crosslinker, on the other. Hence, 
a three-dimensional polyelectrolyte coating was formed on the surface of liposomes, with the aim of 
protecting quercetin from the gastric environment and controlling its release to reach the intestine. 
The cross-linked chitosan/liposome hybrid system was thoroughly characterized by evaluating key 
parameters, also in comparison with the native liposomes and the chitosan-only coated liposomes. 
The morphological investigation of quercetin liposomes by TEM showed small vesicles varying 
from spherical to elongated, irregular shape. The liposome membrane was composed of two or 
more lamellae, thus resulting in oligolamellar structures (Fig. 1A). Chitosomes and TPP-chitosomes 
displayed similar characteristics: they were larger than liposomes, quasi-spherical shaped, and their 
lamellar arrangement was not detectable (Fig. 1B). No drug crystals were visible on TEM images, 
regardless of the step of processing. 
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In agreement with TEM observations, DLS results (Table 1) showed that all the three systems 
prepared were nanosized, being around 120 nm when the quercetin was not loaded, around 140 nm 
when the quercetin was loaded in liposomes, and even larger (180 nm; p < 0.05) when the vesicles 
were coated with chitosan and TPP-chitosan. The P.I. was around 0.4 for all the three systems, 
indicating an acceptable degree of polydispersity. The zeta potential of liposomes was negative (~ -
30 mV; Table 1), due to the charge carried by P90H and P50, which is ideal for binding positively 
charged chitosan. An inversion of the zeta potential was detected upon coating the liposomes with 
the polymer (+46 mV), and as soon as the cross-linking with anionic TPP took place, the zeta 
potential became less positive, approaching neutrality (+2 mV). These results confirm that cross-
linked chitosan formed a shell layer on the outer surface of liposomes, which is expected to protect 
the inner phospholipid structure and the incorporated quercetin. 
The entrapment efficiency (EE%; Table 1) of quercetin in liposomes was 55%, and it was clearly 
affected by the chitosan coating, as it increased to 70% and 91%. This is reasonably due to the fact 
that the free quercetin, which was not entrapped in liposomes, was embedded in the three-
dimensional polyelectrolyte shell during the coating and cross-linking process. 
 
3.2. SAXS analysis 
Further insights into the morphology and lamellar arrangement of the prepared liposomes, as well 
as the effect of the polymer coating and cross-linking, were gained by SAXS, a well established 
technique for the study of self-assembling nanostructures. 
The SAXS curve of empty liposomes showed the typical shape for unilamellar vesicles, that is a 
broad symmetric band (Fig. 2A). The coating with chitosan and the cross-linking with TPP did not 
alter such arrangement, as demonstrated by the similar SAXS profiles (Fig. 2A). On the other hand, 
the presence of quercetin had a moderate effect on the three systems, the most evident being a 
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conformational difference in liposomes, as the scattering curve featured two bumps, which can be 
attributed to vesicle oligolamellarity (Fig. 2C). 
All the SAXS patterns were fitted with two models, one for the symmetric and the other for the 
asymmetric bilayer, and the fitting parameters are reported in Table 2. For liposomes, both the 
models provided an adequate fitting of the scattering curves, as it can be deduced from the slight 
difference in χ2red, being approximately 2 (for purely statistical noise χ2red = 1; for good statistical 
fitting χ2red < 3; χ2red in the range of 5 to 10 = poor fitting). In contrast, the differences in χ2red were 
significant for the chitosomes, and even more pronounced for TPP-chitosomes (~30 vs 2; Table 2), 
pointing to the superiority of the asymmetric model for the fitting of the hybrid systems. 
In order to minimize the fitted parameters, in the asymmetric model we allowed the intensity of the 
external Gaussian to be different from that of the inner Gaussian, preserving both the width and 
position with respect to the bilayer center. It is quite clear from the data summarized in Table 2 that 
chitosan was arranged on the outer surface of liposomes and TPP was entangled with the chitosan 
chains. Indeed, the main effect of chitosan was a reduction of the polar heads separation, with an 
increase in width of the Gaussians corresponding to the polar heads (σh; Table 2). Further, 
proceeding from liposomes, which were symmetric or slightly asymmetric, with the interior layer 
more dense than the outer layer (ρh vs ρh2), to chitosomes, the outer polar head electron density 
increased, and this was even more noticeable for TPP-chitosomes (ρh2, Table 2; Fig. 2B and D). 
Additionally, Zh, which is the distance of the polar heads to the centre of the bilayer, increased for 
liposomes when the quercetin was loaded, suggesting an enlargement of the vesicles. This is 
consistent with the DLS results showing that the mean diameter of liposomes increased from 116 to 
138 nm (Table 1). Such increase in Zh was not observed for the hybrid systems, despite the increase 
in size measured by DLS (from 120 to 180 nm). This confirms the chitosan did not alter the 
assembly of the phospholipids in vesicles, but was rather arranged on the outer surface of liposomes 
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forming a three-dimensional shell when cross-linked with TPP, which caused the enlargement 
detected by DLS. 
 
3.3. X-ray diffraction and DSC analyses 
X-ray diffraction studies were carried out to investigate the microstructure of the drug, the 
phospholipids and the polymer and their interactions in the prepared hybrid system (Fig. 3). The 
raw P90H showed partially crystalline characteristics, with the major peak at approximately 21° 2θ, 
while P50 showed amorphous structure. Cholesterol exhibited several sharp crystal reflections [21], 
TPP was in the monoclinic crystalline phase C2/c (a=16.0, b=5.24, c=11.25 Å, β=93°) [22], and 
quercetin revealed its anhydrous crystalline form, with multiple sharp peaks of different intensities 
between 8° and 32° 2θ [23]. Chitosan exhibited two major peaks at around 13° and 19° 2θ, the first 
one showing stronger intensity, which correspond to the α and β crystal forms and represent the 
typical fingerprints of the semi-crystalline polymer [13,24]. 
For comparative purposes, a physical mixture of the raw components was prepared by gently 
grinding the powders at the same mass ratio as in TPP-chitosomes. The diffractogram of the 
physical mixture was basically a superimposition of the individual patterns of the main components, 
the phospholipids and chitosan (the two amorphous halos were clearly visible), hiding the peaks 
characterizing quercetin, and there was no sign of the formation of a new structure. 
On the other hand, the diffractogram of the TPP-chitosomes exhibited a distinctive pattern, with two 
predominant low-intensity, broad peaks, indicating the structural changes of the components, and 
the presence of chemical interactions between crosslinked-chitosan, quercetin and the phospholipid 
vesicle when they formed the hybrid system. In addition, the high-intensity crystalline peaks of 
quercetin were not detectable, suggesting its amorphization/dispersion when loaded in TPP-
chitosomes. 
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DSC thermal analyses of the raw materials, their physical mixture and quercetin-loaded TPP-
chitosomes are presented in Fig. 4. In the thermogram of P90H, a major endothermic peak was 
detected at 82 °C, while for P50 a set of thermal events was observed between 110 and 295 °C. This 
may be due to the fact that P90H is composed mostly of phosphatidylcholine (not less than 90%), 
which reflects in the major melting peak, while P50 contains 45% phosphatidylcholine plus 10–
18% phosphatidylethanolamine, and triglycerides and lipids (e.g., fatty acids, glycolipids, 
phosphatidylinositol), each one having a different melting point [25]. 
The thermogram of cholesterol showed a sharp endothermic peak at 149 °C, corresponding to its 
melting point, and the curve of TPP displayed three major endothermic peaks at 81, 194 and 295 
°C. The thermogram of chitosan was characterized by two thermal events: the first endothermic 
centred at about 45 °C, attributed to the loss of water associated with the hydrophilic groups of the 
polymer, and the second exothermic centred at about 309 °C, corresponding to the thermal 
degradation of the polymer. The thermogram of quercetin displayed a major sharp endothermic 
peak at 322 °C, which corresponds to the melting point of the drug crystals. This peak was still 
detectable in the curve of the physical mixture, which was an apparent combination of events of the 
phospholipids and chitosan. In contrast, the DSC curve of the TPP-chitosomes showed the complete 
disappearance of the characteristic peak of quercetin, suggesting that it may be molecularly 
dispersed within the phospholipid-polymer system. Further, the DSC profile was markedly different 
from that of the physical mixture, showing broad signals with low intensity, which may be ascribed 
to the presence of physical or chemical interactions in a newly formed system. 
 
3.4. Accelerated stability tests 
The Turbiscan® technology was exploited to detect possible instability phenomena in the prepared 
systems, thus providing an accurate, qualitative description of the vesicular dispersions, in terms of 
demixing behavior and predictive stability. No variation in vesicle size occurred for liposomes 
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stored at 20 and 40 °C for 15 days, since the transmission profile was within the interval ±2% (Fig. 
5). On the other hand, TPP-chitosomes showed a certain instability due to the vesicle migration to 
the top of the cuvette, indicating the occurrence of creaming. The intensity of the phenomenon was 
higher for TPP-chitosomes than for chitosomes, as shown in the ∆T profiles. However, creaming is 
a reversible phenomenon, since the creamed layer can be easily redispersed by gentle shaking. 
On the basis of the TSI results (Fig. 5), the following stability order can be derived: chitosomes ≥ 
liposomes > TPP-chitosomes. These findings are in accordance with the stability profiles observed 
at 24 h for chitosan-coated liposomes by Gonçalves et al. [26], and highlight the important role of 
chitosan in the structural organization of the nanosystem, that is an improvement of the stability. 
These findings are in agreement with the DLS data, and can be related to the zeta potential values of 
the samples. The zeta potential is a well-known, useful tool to predict the sample stability during 
storage, ensured by electrostatic repulsion. When the particles have and maintain a large negative or 
positive zeta potential, like in liposomes (-32 mV) and chitosomes (+46 mV), they repel each other 
and the dispersion is stable. In particles with low zeta potential, like in TPP-chitosomes (+2 mV), 
there is only a little repulsion force and the particles will eventually aggregate, resulting in 
dispersion instability. Overall, it can be inferred that chitosan and TPP critically modified the 
sample stability, with an opposite effect likely correlated with the modification of the surface 
charge of the hybrid system, in accordance with previous findings on the stability enhancement of 
lipid nanoparticles due to the addition of a positively charged coating layer [20]. Nevertheless, as 
mentioned above, it is worth noting that the instability of TPP-chitosomes was reversible, as the 
creamed layer could be easily redispersed by gentle shaking. 
 
3.5. In vitro drug release studies 
The ability of the prepared hybrid system to pass through the acidic environment of the stomach and 
release the incorporated quercetin in the intestine was assessed by conducting drug release studies 
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under conditions mimicking the stomach and intestine environment. The release profiles of 
quercetin from TPP-chitosomes are shown in Fig. 6, as a function of the time and pH of the release 
medium. At acidic pH, the release of quercetin from TPP-chitosomes was not time-dependent, 
reached the maximum amount after 10 minutes, and remained constant up to 2 h. Conversely, at 
intestinal pH, the release was enhanced and time-dependent: after 2 h the amount of drug released 
was 2 times greater than that obtained at pH 1.2, and after 8 h it was 2.7-fold greater. Therefore, it 
can be concluded that the system modulated the release in a pH-dependent fashion. Further, the 
observed sustained release may be attributed to the diffusion of quercetin through the hybrid 
system. 
 
4. Conclusions 
The goal of this work was to design a formulation for the intestinal delivery of quercetin, with great 
potential for health promotion. The development of such system that achieves both therapeutic 
effectiveness and biocompatibility is a challenging task, since quercetin has low oral bioavailability. 
In this context, a cross-linked chitosan/liposome hybrid nanosystem loading quercetin was 
successfully fabricated, without any complicated apparatus or organic solvents. The morphology 
and structure of the system were analysed using different non-invasive techniques, such as light 
scattering, transmission electron microscopy, differential scanning calorimetry and X-ray powder 
diffraction. The system possessed a satisfactory size range (~180 nm) and attractive entrapment 
efficiency (~91%). The formation of a cross-linked, coating layer on the liposome surface, as well 
as the effect of the polymer-mediated conformational change were followed with the help of SAXS 
technique and explained with a proposed model, representing a novel aspect of this work. Indeed, it 
was demonstrated that chitosan did not alter the assembly of the phospholipids in vesicles, but was 
rather arranged on the outer surface of liposomes forming a three-dimensional shell when cross-
linked with TPP, which caused an increase in size of the system. 
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The use of a protective three-dimensional polyelectrolyte shell layer was expected to allow 
circumventing possible damage of both the vesicles and the incorporated drug due to the acidic pH 
of the stomach. From in vitro tests, it was found that the system modulated the release of quercetin 
as a function of the pH (preferably alkaline), and it was likely governed by the diffusion of the drug 
through the hybrid system. 
In conclusion, several insights to understand the structure of the hybrid system and its potential as 
smart carrier in drug delivery applications, especially for the therapy of intestinal inflammatory-
based disorders, were given. We anticipate that this study would provide a better understanding of 
the advantages of combining liposomes and chitosan, paving the way for the next investigations that 
will be carried out on the proposed system, by changing the amount of both the quercetin and the 
polymer, to confirm the obtained results and to model the release properties of the system. Further 
studies are also required to evaluate the fate and the therapeutic efficacy of the hybrid system in 
vivo, upon oral administration. 
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Captions to Figures 
 
Fig. 1. TEM images of liposomes (A) and TPP-chitosomes (B). The arrows indicate the lamellae of 
liposomes. 
 
Fig. 2. SAXS (A-C) and electron density (B-D) profiles of empty and quercetin-loaded liposomes, 
chitosomes and TPP-chitosomes. The lines correspond to the best fits of Gaussian bilayer models: 
see the text for details on the fitting. 
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Fig. 3. X-ray diffractograms of raw components, physical mixture and TPP-chitosomes. 
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Fig. 4. DSC thermograms of raw components, physical mixture and TPP-chitosomes. 
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Fig. 5. Transmission profiles (∆T) of liposomes (A), chitosomes (B) and TPP-chitosomes (C) stored 
at 20 and 40 °C. The data are represented as a function of time (0-15 days) and sample height (0 to 
20 mm). The progression of the analysis over time is indicated by the arrow. 
The Turbiscan stability index (TSI) of liposomes, chitosomes and TPP-chitosomes stored at 20 and 
40 °C is also presented. 
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Fig. 6. Quercetin release from TPP-chitosomes over 2 hours at pH 1.2 and over 8 hours at pH 7.0, at 
37 °C. Error bars represent standard deviation, n = 3. 
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Table 1 
Main features of empty and quercetin-loaded systems: average size; polydispersity index, P.I.; zeta 
potential, ZP; entrapment efficiency, EE%. Values are the means ± standard deviation (n = 6). 
 Size nm ± SD P.I.a ZP mV ± SD EE% 
 
Empty liposomes 116 ± 4.5 0.38 -20 ± 5.4  
Empty 
chitosomes 
119 ± 2.0 0.44 +23 ± 9.3 
 
 
Empty TPP-
chitosomes 
120 ± 2.9 0.46 +1.6 ± 0.8 
 
 
QUE liposomes 138 ± 6.3 0.38 -32 ± 3.6 55 ± 7.0 
QUE chitosomes 174 ± 5.1 0.39 +46 ± 9.3 70 ± 10.0 
 
QUE TPP-
chitosomes 
182 ± 7.0 0.42 +2.3 ± 2.1 91 ± 1.0 
 
     
a SD for P.I. values was always ≤0.02. 
 
Table 2A. Comparison of the fitting parameters obtained from the symmetric (left column) and asymmetric 
(right column) models for the empty samples shown in figure 2. 
 Liposomes Chitosomes TPP-chitosomes 
χ2red
1 2.6 2.3 3.7 1.1 34.9 1.9 
σh
2 
5.5±0.5 5.6±0.5 5.8±0.5 8.0±0.5 1.3±0.5 10.1 ±0.5 
ρh
3 0.57±0.03 0.49±0.05 0.37±0.04 0.4±0.04 1. 7±0.2 0.3±0.08 
Zh
4 
20.8±1.0 20.8±1.0 20.6±1.0 18.7±1.0 16.0±2.0 17.5±1.0 
26 
 
σc
5 
4.2±0.5 4.0±0.5 3.1±0.5 5.1±0.5 8.8±1.0 3. 8±0.5 
ρh2
6  0.7±0.08  0.6±0.05  0.8±0.10 
 
Table 2B. Comparison of the fitting parameters obtained from the symmetric (left column) and asymmetric 
(right column) models for the quercetin loaded samples shown in figure 2. 
 Liposomes7 Chitosomes TPP-chitosomes 
χ2red 2.4 1.9 6.4 1.07 30.6 2.7 
σh 4.4±0.5 6.0±0.5 6.0±0.5 8.2±0.5 1.5±0.5 9.2±0.5 
ρh 0.63±0.04 0.6±0.04 0.5±0.1 0.46±0.04 1.2±0.2 0.5±0.08 
Zh 22.4±1.0 22.0±1.0 20.3±1.0 18.4±1.0 15.9±2.0 17.5±1.0 
σc 4.0±0.5 3.4±0.5 4.1±0.5 5.6±0.5 7.6±1 5.0±0.5 
ρh2  0.4±0.07  0.70±0.05  1.3±0.15 
1χ2red =1 for a perfectly statistical fit, values of 2 or 3 are reasonably good. 
2σh corresponds to the polar head gaussian amplitude in Å. 
3ρh corresponds to the polar head relative electron density (-1 for the methyl groups). 
4Zh the center of the polar head gausian with respect to the bilayer centre in Å. 
5σc the methyl deep amplitude in Å. 
6ρh2 only appears for the assymetric model and corresponds to the outer polar head electron density. 
7 This sample showed significant multilamelarity, with a repetition distance of 81.1±0.5 Å, a Caillé 
paremeter of  0.25±0.02 and 1.5±0.2 correlated bilayers. 
 
 
